[获得的血友病:2024年更新]
Hervé Lévesque1, Benoit Guillet2, Roseline d'Oiron3
1Service de médecine interne, CHU de Rouen, Normandie université, UNIROUEN, U 1096, 1, rue de Germont, 76000 Rouen, France.
概括
获得性血友病A (AHA) 是一种罕见的自身免疫性出血疾病,由因子VIII自身抗体引起. 早期诊断和用血液静止剂和免疫抑制剂治疗对于管理这种高死亡率的疾病至关重要.
科学领域:
- 血液学 血液学 血液学
- 自体免疫学 自体免疫学
- 内部医学 内部医学
背景情况:
- 获得性血友病A (AHA) 是一种罕见的自身免疫性疾病,其特征是对因子VIII的自身抗体.
- 它呈现出异常出血,特别是皮下出血,以及长时间的激活部分血栓形成时间 (aPTT).
- AHA可能是异常性或与自身免疫性疾病,恶性瘤,怀孕或药物使用有关.
研究的目的:
- 审查AHA的流行病学,病原性,诊断和治疗.
- 讨论当前管理获得的血友病A.A.的建议.
- 为了提供对这种罕见的出血障碍的全面概述.
主要方法:
- 对AHA的流行病学,发病性,诊断和治疗策略的文献综述.
- 临床数据和治疗结果的分析.
- 讨论当前的临床指南和专家建议.
主要成果:
- 在患有不明原因出血和长时间aPTT的患者中,AHA诊断需要怀疑.
- 治疗涉及血液静止剂 (例如,因子VIIa,激活的前热血素复合物) 来控制出血.
- 抑制剂的消灭通常需要用类固醇,细胞毒剂或rituximab进行免疫抑制.
结论:
- 快速诊断和多学科管理对于改善AHA结果至关重要.
- 治疗策略应同时解决血液静止和抑制剂消灭问题.
- 需要进一步的研究来优化获得的血友病A的治疗方案.
相关概念视频
Disorders of Hemostasis
740
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
740
Anticoagulant Drugs: Low-Molecular-Weight Heparins
652
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
652
Extrinsic and Intrinsic Pathways of Hemostasis
6.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.5K
Introduction to Hemostasis
6.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.6K
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K


